In addition, even if not directly investigated in SSc, hepatocyte growth factor and the aldosterone receptor-blocker spironolactone were found to prevent TGF-β1-induced EndoMT in human umbilical vein ECs [119,149,150]. This evidence concerns the gene TGFB1 and systemic sclerosis.